Feb 12 (Reuters) - AbbVie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for Medicare & Medicaid Services to impose price controls for ...
AbbVie has sued the Department of Health and Human Services (HHS), challenging the agency’s decision to select its blockbuster anti-wrinkle therapy Botox for the next round of Medicare price ...
AbbVie says Congress excluded Botox from price controls Lawsuit alleges multiple constitutional violations Botox contributes over 10% to AbbVie's annual revenue HHS declines to comment Feb 12 (Reuters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results